1Imagawa A, anafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and absence of diabetes-related antibodies. N Eng J Med, 2000, 342: 301.
3Imagawa A,Hanafusa T,Uchigata Y,et al. Fulminant type 1 diabetes: A nationwide survey in Japan. Diabetes Care, 2003,26: 2345.
4Cho YM, Kim JT, Ko KS,et al. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia,2007, 50 : 2276.
5Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA, 2001,285:1153.
6Hanafusa T,Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab,2007,3:36.
7Shimizu I,Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab,2006,91:471.
8Shimizu I,Makino H,Osawa H, et al. Association of fulminant type 1 diabetes with pregnancy. Diabetes Res Clin Pract, 2003, 62 : 33.
9Chien CC, Chung WH, Hung SI, et al. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol,2006,54: S14.
10Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia,2005,48:290.
二级参考文献19
1Taniyama M, Katsumata R, Aoki K, et al. A Fillipino patient with fulminant type 1 diabetes. Diabetes Care, 2004, 27:842-843.
2Imagawa A,- Hanafusa T, Uchigata Y, et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia,2005, 48:294-300.
3Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia,2005, 48:290-293.
4Yadav D, Nair S, Norkus EP, et al. Nonspecitic hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol,2000, 95:3123-3128.
5Semakula C, Vandewalle CL, Van Schravendijk CF, et al.Abnormal pancreatic enzyme activities in more than twenty-five percent recent onset insulin-dependent diabetic patients: association of hyperlipasemia with high titre islet-cell antibodies. Pancreas,1996,12:321-333.
6Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997,20:1183-1197.
7Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15:539-553.
8Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med, 2000, 342:301-307.
9Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes. A nationwide survey in Japan. Diabetes Care, 2003, 26:2345-2352.
10Maldonado MM, Hampe CS, Gaur LK, et al. Ketosis-Prone diabetes : dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003,88:5090-5098.
9Imagawa A,Anafusa T,Miyagawa J,et al.A novel subtype of typel diabetes mellitus characterized by a rapid onset and absence of diabetes -related antibodies[J].N Eng J Med,2000,342:301.
10Sekine N,Motokura T,Oki T,et al.Rapid loss of insulin secretion in a patient with fulminant type1 diabetes mellitus and carbamazepine hypersensitivity syndrome[J].JAMA,2001,285:1153.
